dr. finn on the promise of regorafenib for the treatment of hcc
Published 7 years ago • 256 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
3:06
dr. finn on tivantinib and regorafenib for the treatment of liver cancer
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
1:34
dr. finn on results of resource study in liver cancer
-
1:45
dr. finn on current and emerging agents in the field of hcc
-
0:49
dr. daniele on impact of regorafenib in hcc
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
3:48
clinical experience with regorafenib in hcc
-
2:18
dr. richard finn on the difficulties of treating liver cancer
-
5:31
practical advice for using regorafenib
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
7:46
clinical use of regorafenib in mhcc
-
7:01
global use of regorafenib in hcc
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
5:22
impact of resorce findings on hcc clinical practice
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
9:34
regorafenib in colorectal cancer
-
7:09
global use of regorafenib in hcc
-
2:13
dr. lenz on the benefit of regorafenib in crc